Skip to content

Patellofemoral pain syndrome: long term follow-up outcomes of a randomized controlled trial

Patellofemoral pain syndrome: long term follow-up outcomes of a randomized controlled trial - Patellofemoral pain syndrome: long term outcomes

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON37666
Enrollment
131
Registered
2012-06-28
Start date
2012-03-01
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

knee complaints

Interventions

None listed

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: At baseline, patients with patellofemoral painsyndrome (the presence of at least three of the following symptoms: pain when walking up or down stairs; pain when squatting; pain when running; pain when cycling; pain when sitting with knees flexed for a prolonged period of time; grinding of the patella; and a positive clinical patellar test (such as Clarke*s test or patellar femoral grinding test)) were included. All patients that had participated in the randomised clinical trail will be included in the follow-up study. These patients will be 18 years and older at the 6-year follow-up study.

Exclusion criteria

Exclusion criteria: At baseline, patients were excluded if they had knee osteoarthritis, patellar tendinopathy, Osgood-Schlatter disease, or other defined pathological conditions of the knee, or had previous knee injuries or surgery. Patients who have indicated in the past that they wish not longer to participate in the study will be excluded in this 6 year follow-up study

Design outcomes

Primary

MeasureTime frame
Primary outcomes are recovery (7-point Likert scale), semi-quantative features of the patellofemoral joint.

Secondary

MeasureTime frame
Pain, function, medical consumption, sport activity.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)